Human genetic evidence supports fibroblast growth factor 21 as a novel therapeutic target for gout

Rheumatology (Oxford). 2024 Oct 1;63(10):e288-e289. doi: 10.1093/rheumatology/keae210.

Sizheng Steven Zhao¹, Daniel J Cuthbertson^{2

3}, Uazman Alam^{3

4

5}

¹ Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Science, School of Biological Sciences, Faculty of Biological Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
² Department of Cardiovascular and Metabolic Medicine, University of Liverpool, Liverpool, UK.
³ Department of Medicine, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
⁴ Department of Cardiovascular and Metabolic Medicine, Liverpool Centre for Cardiovascular Science and the Pain Research Institute, University of Liverpool, Liverpool, UK.
⁵ Centre for Biomechanics and Rehabilitation Technologies, Staffordshire University.

No abstract available

Publication types